Heather Turner
Chief Executive Officer at Carmot Therapeutics, Inc.
Heather Turner active positions
Companies | Position | Start | End |
---|---|---|---|
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - | - |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Director/Board Member | 2022-09-20 | - |
Chief Executive Officer | 2022-12-31 | - | |
President | 2022-12-31 | - | |
Chief Operating Officer | 2022-09-20 | - |
Career history of Heather Turner
Former positions of Heather Turner
Companies | Position | Start | End |
---|---|---|---|
LYELL IMMUNOPHARMA, INC. | General Counsel | 2019-03-31 | 2023-07-04 |
Corporate Secretary | 2019-11-30 | 2023-07-04 | |
SANGAMO THERAPEUTICS, INC. | General Counsel | 2018-02-11 | 2019-03-14 |
Corporate Secretary | - | 2019-03-14 | |
ATARA BIOTHERAPEUTICS, INC. | General Counsel | 2015-06-30 | 2018-01-31 |
Corporate Secretary | 2015-06-30 | 2018-01-31 | |
OREXIGEN THERAPEUTICS, INC. | General Counsel | 2007-05-31 | 2015-06-24 |
Corporate Secretary | 2007-05-31 | 2015-06-24 | |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 2005-06-30 | 2007-05-31 |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Corporate Officer/Principal | 1998-12-31 | 2004-12-31 |
Training of Heather Turner
University of California, Santa Barbara | Undergraduate Degree |
UCLA School of Law | Graduate Degree |
Statistics
International
United States | 11 |
Operational
General Counsel | 4 |
Corporate Secretary | 4 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
LYELL IMMUNOPHARMA, INC. | Health Technology |
Private companies | 5 |
---|---|
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Heather Turner
- Experience